Browsing by Subject "NSCLC"
Now showing items 1-4 of 4
-
Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
(Brac University, 2024-02)This work addresses computational approaches to non-small cell lung cancer (NSCLC) drug discovery, highlighting the vital part that molecular docking plays in the early stages of drug discovery. It demonstrates the ... -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
(Brac University, 2023-01)Research is required in the area of non-small cell lung cancer, due to its widespread prevalence. Efforts to enhance the accessibility, evaluative simplicity, and prediction accuracy of endpoints in clinical trials are ... -
Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
(Brac University, 2023-10)Lung cancer is a prominent cause of death annually. It is the most common cancer worldwide and the leading cause of cancer deaths in men and women. In this research, we focused mostly on non-small cell lung cancer (NSCLC) ... -
Safety and efficacy of cisplatin combinations with vinorelbine, paclitaxel and gemcitabine – a systematic review and meta-analysis
(Brac University, 2023-06)Introduction: The aim of the study is to assess the efficacy of cisplatin combinations with paclitaxel, gemcitabine and vinorelbine for the first line treatment of non-small cell lung cancer.Methods: The Cochrane library, ...
